Dexpramipexole
| Dexpramipexole | |
|---|---|
| Dexpramipexole.png | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Dexpramipexole is a small molecule drug that has been investigated for its potential use in treating neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). It is a chirally pure form of the drug pramipexole, which is used in the treatment of Parkinson's disease.
Mechanism of Action[edit]
Dexpramipexole is believed to work by enhancing the function of mitochondria, the energy-producing organelles in cells. This enhancement may help protect neurons from degeneration, which is a hallmark of diseases like ALS. The exact mechanism by which dexpramipexole exerts its effects is not fully understood, but it is thought to involve the modulation of mitochondrial function and reduction of oxidative stress.
Clinical Development[edit]
Dexpramipexole has undergone several clinical trials to assess its efficacy and safety in patients with ALS. Initial studies showed promise, with some patients experiencing a slower progression of the disease. However, a large Phase III clinical trial did not demonstrate a statistically significant benefit in slowing the progression of ALS compared to placebo.
Potential Applications[edit]
While the primary focus of dexpramipexole research has been on ALS, there is interest in exploring its potential use in other neurodegenerative conditions, such as Huntington's disease and Alzheimer's disease. The drug's ability to modulate mitochondrial function makes it a candidate for diseases characterized by mitochondrial dysfunction.
Challenges and Future Directions[edit]
The failure of dexpramipexole to show significant efficacy in late-stage clinical trials for ALS has led to a reevaluation of its potential. Researchers are investigating whether different dosing regimens, combination therapies, or targeting specific patient subgroups might yield better results. Additionally, ongoing research into the drug's mechanism of action may uncover new therapeutic targets or applications.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
